| Open: | 0.43 | High: | 0.43 | | Low: | 0.43 | Volume: | 1,200 | | Yield: | n/a | P/E Ratio: | n/a | | Bid: | 0.35 | Ask: | 0.48 | | Ex Div. Date: | n/a | Ex Div. Amount: | n/a |
| Overview: |
Oramed Pharmaceuticals Inc. (Oramed) is a development-stage pharmaceutical company. The Company is engaged in the research and development of pharmaceutical solutions, including an orally ingestible insulin capsule or tablet to be used for the treatment of individuals with diabetes, rectal application of insulin, use of oral ingestible capsules or tablets for delivery other polypeptides and use of rectal application for delivery of other polypeptides. As of August 31, 2009, the Company had not generated any revenues.
|
| Contact: |
No information available. |
Spam Report:  |
1 possible spam reported.
Latest spam reported on 03-23-2007
[ view the detailed ORMP spam report ] |
|
Subscribe to our newsletter to get free stock market tips and investment advice! (323 subscribers)
RSS Feed
XHTML
RSS